Product Information

Bifeprunox is a biphenyl compound.

CAS No.	350992-10-8
Product Name	Bifeprunox

Biological Targets

DRD2·HTR1A

Associated Conditions

bipolar disorder·schizophrenia·bipolar I disorder·Alzheimer disease·schizoaffective disorder·

* The information provided here is compiled from public sources and is for reference only.

Studies related to this compound and its mechanism of action

In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.

Naunyn-Schmiedeberg's archives of pharmacology • Vol. 373, Issue 6 • 2006

PMID: 16947046 DOI: 10.1007/s00210-006-0092-z

Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.

European journal of pharmacology • Vol. 535, Issue 1-3 • 2006

PMID: 16554049 DOI: 10.1016/j.ejphar.2006.01.051

Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase.

European journal of pharmacology • Vol. 534, Issue 1-3 • 2006

PMID: 16497294 DOI: 10.1016/j.ejphar.2006.01.027

Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology • Vol. 31, Issue 9 • 2006

PMID: 16237379 DOI: 10.1038/sj.npp.1300940

Bifeprunox

CAS No.	350992-10-8
MDL No.	N/A
MF	C₂₄H₂₃N₃O₂
MW	385.50
InChI Key	CYGODHVAJQTCBG-UHFFFAOYSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT

Pricing & Availability

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Bifeprunox is a biphenyl compound.

CAS No.	350992-10-8
Product Name	Bifeprunox

Biological Targets

DRD2·HTR1A

Associated Conditions

bipolar disorder·schizophrenia·bipolar I disorder·Alzheimer disease·schizoaffective disorder·

* The information provided here is compiled from public sources and is for reference only.

Bifeprunox

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Bifeprunox

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

Bifeprunox

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.

Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.

Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase.

Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.

Similar Products

Bifeprunox Mesylate

Bifeprunox

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.

Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.

Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase.

Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.

Similar Products

Bifeprunox Mesylate

Documentation